| Sep'11 | Jun'11 | Sep'10 | Jun'10 | ||
|---|---|---|---|---|---|
Operating revenues - equipment sales and related services | |||||
0 | 0 | 0 | 0 | ||
Operating revenues - cryobanking and related services | |||||
0 | 0 | 0 | 0 | ||
Total Revenues | |||||
0 | 0 | 0 | 0 | ||
Costs of sales-equipment sales and related services | |||||
0 | 0 | 0 | 0 | ||
Costs of sales-cryobanking and related services | |||||
0 | 0 | 0 | 0 | ||
Total Costs of Sales | |||||
0 | 0 | 0 | 0 | ||
Gross Profit | |||||
0 | 0 | 0 | 0 | ||
Research and development-equipment sales and related services | |||||
0 | 0 | 0 | 0 | ||
Research and development-cryobanking and related services | |||||
0 | 0 | 0 | 0 | ||
Total Research and Development Expenses | |||||
0 | 0 | 0 | 0 | ||
Selling, general, and administrative- equipment sales and related services | |||||
0 | 0 | 0 | 0 | ||
Selling, general and administrative- cryobanking and related services | |||||
0 | 0 | 0 | 0 | ||
Total Selling, General and Administrative Expenses | |||||
0 | 0 | 0 | 0 | ||
Total Operating Expenses | |||||
0 | 0 | 0 | 0 | ||
Loss from Operations | |||||
0 | 0 | 0 | 0 | ||
Dividend income-investment portfolio | |||||
0 | 0 | 0 | 0 | ||
Realized gains on sale of securities, net | |||||
0 | 0 | 0 | 0 | ||
Mark to market of short positions | |||||
0 | 0 | 0 | 0 | ||
Other revenues | |||||
0 | 0 | 0 | 0 | ||
Interest expense | |||||
0 | 0 | 0 | 0 | ||
Administrative expenses relating to portfolio investments | |||||
0 | 0 | 0 | 0 | ||
Total Other (expense) income, net | |||||
0 | 0 | 0 | 0 | ||
(Loss) Income before income taxes | |||||
0 | 0 | 0 | 0 | ||
(Benefit ) provision for income taxes | |||||
0 | 0 | 0 | 0 | ||
Net (Loss) Income | |||||
0 | 0 | 0 | 0 | ||
Net Income (Loss) | |||||
0 | 0 | 0 | 0 | ||
Unrealized (Loss )Gain on Securities Held for Sale, Net of Deferred Income Taxes | |||||
0 | 0 | 0 | 0 | ||
Comprehensive (Loss) Income | |||||
0 | 0 | 0 | 0 | ||
Weighted average number of shares outstanding basic and diluted (in Shares) | |||||
4,219,026 | 4,225,349 | 4,232,691 | 4,242,285 | ||
Net (loss) income per common equivalent share basic and diluted (in Dollars per share) | |||||
-0.99 | -0.04 | 0.62 | 0.04 | ||
Dividends paid per common share (in Dollars per share) | |||||
- | 0.15 | 0.25 | 0.10 | ||